FIELD: pharmaceutics.
SUBSTANCE: group of inventions relates to the field of pharmaceutics, namely to methods for the treatment of an irregular sleep-wake rhythm, associated increased sleepiness and/or daytime drowsiness, a disorder of a circadian sleep rhythm due to Alzheimer’s disease, selected from sleep interruption, sleep-wake fragmentation and irregular sleep-wake rhythm, to methods for the improvement of nighttime sleep continuity, behavioral and cognitive problems in a subject with an irregular sleep-wake rhythm, with dementia due to Alzheimer’s disease, with mild cognitive impairment due to Alzheimer’s disease, to methods for the stabilization and improvement of one or several circadian rhythms in a subject. Methods include the injection of the effective amount of at least one compound selected from ((1R,2S)-2-(((2,4-dimethylpyrimidine-5-yl)oxy)methyl)-2-(3-fluorophenyl)-N-(5-fluoropyridine-2-yl)cyclopropancarboxamide, its pharmaceutically acceptable salts and solvates, once a day every day before sleep or once a day every other day before sleep.
EFFECT: group of inventions provides for the creation of safe and effective therapy that is easy for the injection for the treatment of sleep-wake fragmentation in patients with an irregular sleep-wake rhythm.
42 cl, 2 dwg, 2 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
USE OF AN INVERSE AGONIST H3R FOR TREATING SLEEP DISORDER IN SHIFT WORK | 2018 |
|
RU2768894C2 |
NEW COMBINATIONS OF H3 RECEPTOR ANTAGONISTS AND NOREPINEPHRINE REUPTAKE INHIBITORS AND THEIR THERAPEUTIC USE | 2019 |
|
RU2809163C2 |
METHOD OF TREATING EXCESSIVE DAYTIME SLEEPINESS (VERSIONS) | 2006 |
|
RU2417077C2 |
HETEROCYCLIC COMPOUND AS INHIBITOR OF CASEIN KINASE 1δ AND/OR ACTIVIN RECEPTOR-LIKE KINASE 5 | 2021 |
|
RU2810065C1 |
MELATONIN AGONIST THERAPY | 2007 |
|
RU2488392C2 |
TREATMENT OF CIRCADIAN RHYTHM DISORDERS | 2013 |
|
RU2748386C2 |
METABOLITES (1R-TRANS)-N-[[2-(2,3-DIGIDRO-4-BENZOFURANYL)CYCLOPROPYL]-METHYL]PROPANAMIDE | 2013 |
|
RU2632889C2 |
WAY TO IMPROVE SLEEP | 2020 |
|
RU2804441C2 |
METHODS FOR THE USE OF CYCLIC AMIDE DERIVATIVES FOR TREATMENT OF SIGMA-RECEPTOR-MEDIATED DISORDERS | 2011 |
|
RU2746871C2 |
SYSTEM AND METHOD FOR PHOTOTHERAPY | 2009 |
|
RU2545904C2 |
Authors
Dates
2021-12-29—Published
2017-05-11—Filed